TUMOR INFILTRATING LYMPHOCYTES - THE EFFECT OF BACILLUS-CALMETTE-GUERIN ON HELPER SUPPRESSOR-T CELL RATIOS OF TREATED AND UNTREATED TUMORS

被引:6
作者
RUBENSTEIN, M
MUCHNIK, S
CHET, M
SHAW, MW
MCKIEL, CF
GUINAN, PD
机构
[1] RUSH PRESBYTERIAN ST LUKES MED CTR,DEPT UROL,CHICAGO,IL 60612
[2] RUSH PRESBYTERIAN ST LUKES MED CTR,DEPT BIOCHEM,CHICAGO,IL 60612
关键词
IMMUNOTHERAPY; ADOPTIVE; LYMPHOCYTES; BCG VACCINE; PROSTATIC NEOPLASMS;
D O I
10.1016/S0022-5347(17)38205-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Copenhagen X Fischer rats bearing single and bilateral Dunning R3327 AT-3 tumors were either treated or not treated at a single site with bacillus Calmette Guerin (BCG). One week later tumors were removed, tumor infiltrating lymphocytes (TIL's) isolated, and then characterized for total-T, helper-T and suppressor-T cell subsets utilizing monoclonal antibodies. The purpose was to determine the effect of BCG on TIL's in treated as well as untreated tumors. In summary: 1) BCG treatment significantly alters TIL distributions at both injected and noninjected sites; 2) a noninjected contralateral tumor compromises the effectiveness of BCG therapy at the suppressor T cell level; 3) contralateral tumors, whether inoculated or not, have similar TIL distributions.
引用
收藏
页码:1650 / 1653
页数:4
相关论文
共 30 条
[1]  
BOYUM A, 1968, SCAND J CLIN INVEST, V21, P177
[2]   RELATIONSHIP OF ARACHIDONIC-ACID METABOLISM TO INDOMETHACIN-SENSITIVE IMMUNOREGULATORY FUNCTION AND LYMPHOCYTE PGE SENSITIVITY IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF DISSEMINATED SOLID TUMOR-CANCER PATIENTS [J].
BRAUN, DP ;
HARRIS, JE ;
RUBENSTEIN, M .
JOURNAL OF IMMUNOPHARMACOLOGY, 1984, 6 (03) :227-236
[3]   2 SUBSETS OF RAT LYMPHOCYTES-T DEFINED WITH MONOCLONAL-ANTIBODIES [J].
BRIDEAU, RJ ;
CARTER, PB ;
MCMASTER, WR ;
MASON, DW ;
WILLIAMS, AF .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1980, 10 (08) :609-615
[4]  
DAVIES M, 1982, CANCER IMMUNOL IMMUN, V14, P46
[5]   BACILLUS CALMETTE-GUERIN IN THE MANAGEMENT OF BLADDER-CANCER [J].
DROLLER, MJ .
JOURNAL OF UROLOGY, 1986, 135 (02) :331-333
[6]   BCG IN MANAGEMENT OF SUPERFICIAL BLADDER-CANCER [J].
GUINAN, P ;
CRISPEN, R ;
RUBENSTEIN, M .
UROLOGY, 1987, 30 (06) :515-519
[7]   HISTOPATHOLOGY OF BCG AND THIOTEPA TREATED BLADDERS [J].
GUINAN, P ;
SHAW, M ;
RAY, V .
UROLOGICAL RESEARCH, 1986, 14 (04) :211-215
[8]  
GUINAN PD, 1982, AM J CLIN ONCOL-CANC, V5, P65
[9]   HISTOPATHOLOGY OF TUMOR REGRESSION AFTER INTRALESIONAL INJECTION OF MYCOBACTERIUM-BOVIS .4. DEVELOPMENT OF IMMUNITY TO TUMOR-CELLS AND BCG [J].
HANNA, MG ;
SNODGRASS, MJ ;
ZBAR, B ;
RAPP, HJ .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1973, 51 (06) :1897-1908
[10]  
HANNA MG, 1988, J CELL BIOCH SE, V12, pA125